Paper3045443
Mechanisms of cellular resistance to cisplatin.
Hospers GA and 2 others. Med Oncol Tumor Pharmacother, 1988. Cited by 43 papers, by iCite.
Cite this record
ConductScience Library. Mechanisms of cellular resistance to cisplatin. Papers, record 3045443. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3045443
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cisplatin | Major topic |
| Biological Transport | |
| Cell Membrane | |
| Cell Nucleus | |
| Cytoplasm | |
| DNA, Neoplasm | |
| Drug Resistance | |
| Humans | |
| Neoplasms |
Source PubMed
References50
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 6941274 | Amplification of the metallothionein-I gene in cadmium-resistant mouse cells. | Proc Natl Acad Sci U S A | 1981 | https://conductscience.org/library/papers/6941274 | PubMed |
| 2 | 6408733 | Depletion of intracellular polyamines may alter DNA conformation in 9L rat brain tumor cells. | Science | 1983 | https://conductscience.org/library/papers/6408733 | PubMed |
| 3 | 7387835 | Inter-species comparisons of carcinogenicity. | Br J Cancer | 1980 | https://conductscience.org/library/papers/7387835 | PubMed |
| 4 | 3539322 | Characterization of a cis-diamminedichloroplatinum(II)-resistant human ovarian cancer cell line and its use in evaluation of platinum analogues. | Cancer Res | 1987 | https://conductscience.org/library/papers/3539322 | PubMed |
| 5 | 3085924 | Effect of alpha-difluoromethylornithine alone and in combination with doxorubicin hydrochloride, cis-diamminedichloroplatinum (II), and vinblastine sulfate on the growth of P3J cells in vitro. | Cancer Res | 1986 | https://conductscience.org/library/papers/3085924 | PubMed |
| 6 | 6890712 | New chemistry of an old molecule: cis-[Pt(NH3)2Cl2]. | Science | 1982 | https://conductscience.org/library/papers/6890712 | PubMed |
| 7 | 3802077 | cis-Diamminedichloroplatinum (II)-DNA adduct formation in renal, gonadal, and tumor tissues of male and female rats. | Cancer Res | 1987 | https://conductscience.org/library/papers/3802077 | PubMed |
| 8 | 3539321 | Characterization of a human squamous carcinoma cell line resistant to cis-diamminedichloroplatinum(II). | Cancer Res | 1987 | https://conductscience.org/library/papers/3539321 | PubMed |
| 9 | 6542297 | Tumours from a cell strain with a high content of metallothionein show enhanced resistance against cis-dichlorodiammineplatinum. | Acta Pharmacol Toxicol (Copenh) | 1984 | https://conductscience.org/library/papers/6542297 | PubMed |
| 10 | 2431772 | Changes in calcium channel activity in membranes from cis-diammine-dichloroplatinum(II)-resistant and -sensitive L1210 cells. | Cancer Res | 1987 | https://conductscience.org/library/papers/2431772 | PubMed |
| 11 | 7192601 | DNA cross-linking as an indicator of sensitivity and resistance of mouse L1210 leukemia to cis-diamminedichloroplatinum(II) and L-phenylalanine mustard. | Cancer Res | 1981 | https://conductscience.org/library/papers/7192601 | PubMed |
| 12 | 3708576 | Properties of amino acid transport systems in K562 cells sensitive and resistant to cis-diamminedichloroplatinum(II). | Cancer Res | 1986 | https://conductscience.org/library/papers/3708576 | PubMed |
| 13 | 3802104 | Prevention of lethal and renal toxicity of cis-diamminedichloroplatinum(II) by induction of metallothionein synthesis without compromising its antitumor activity in mice. | Cancer Res | 1987 | https://conductscience.org/library/papers/3802104 | PubMed |
| 14 | 3741760 | The relationship between cisplatin sensitivity and drug uptake into mammalian cells in vitro. | Br J Cancer | 1986 | https://conductscience.org/library/papers/3741760 | PubMed |
| 15 | 3768295 | Chemical reactivity of monofunctional platinum-DNA adducts. | Biochemistry | 1986 | https://conductscience.org/library/papers/3768295 | PubMed |
| 16 | 2870801 | Covalent binding of 1,2-dihaloalkanes to DNA and stability of the major DNA adduct, S-[2-(N7-guanyl)ethyl]glutathione. | Cancer Res | 1986 | https://conductscience.org/library/papers/2870801 | PubMed |
| 17 | 6300219 | Effect of cisplatin on the plasma membrane phosphatase activities in ascites sarcoma-180 cells: a cytochemical study. | J Histochem Cytochem | 1983 | https://conductscience.org/library/papers/6300219 | PubMed |
| 18 | 6216456 | Detection and quantification of adducts formed upon interaction of diamminedichloroplatinum (II) with DNA, by anion-exchange chromatography after enzymatic degradation. | Nucleic Acids Res | 1982 | https://conductscience.org/library/papers/6216456 | PubMed |
| 19 | 4040369 | Augmentation of adriamycin, melphalan, and cisplatin cytotoxicity in drug-resistant and -sensitive human ovarian carcinoma cell lines by buthionine sulfoximine mediated glutathione depletion. | Biochem Pharmacol | 1985 | https://conductscience.org/library/papers/4040369 | PubMed |
| 20 | 3886121 | Fundamental studies with cisplatin. | Cancer | 1985 | https://conductscience.org/library/papers/3886121 | PubMed |
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 43 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 37110640 | The Challenging Treatment of Cisplatin-Resistant Tumors: State of the Art and Future Perspectives. | Molecules | 2023 | https://conductscience.org/library/papers/37110640 | PubMed |
| 12655051 | New clues for platinum antitumor chemistry: kinetically controlled metal binding to DNA. | Proc Natl Acad Sci U S A | 2003 | https://conductscience.org/library/papers/12655051 | PubMed |
| 8422692 | Correlation of the in vitro cytotoxicity of ethyldeshydroxysparsomycin and cisplatin with the in vivo antitumour activity in murine L1210 leukaemia and two resistant L1210 subclones. | Cancer Chemother Pharmacol | 1993 | https://conductscience.org/library/papers/8422692 | PubMed |
| 2322989 | Enhancement of cisplatin (DDP) antitumor activity by 3-aminobenzamide in rat ovarian tumors sensitive and resistant to DDP in vivo. | Cancer Chemother Pharmacol | 1990 | https://conductscience.org/library/papers/2322989 | PubMed |
| 2005898 | Cross-resistance to UV radiation of a cisplatin-resistant human cell line: overexpression of cellular factors that recognize UV-modified DNA. | Mol Cell Biol | 1991 | https://conductscience.org/library/papers/2005898 | PubMed |
| 1872817 | Identification of inducible damage-recognition proteins that are overexpressed in HeLa cells resistant to cis-diamminedichloroplatinum (II). | Biochem J | 1991 | https://conductscience.org/library/papers/1872817 | PubMed |
| 1540136 | Damage-recognition proteins as a potential indicator of DNA-damage-mediated sensitivity or resistance of human cells to ultraviolet radiation. | Biochem J | 1992 | https://conductscience.org/library/papers/1540136 | PubMed |
| 1503895 | Modulation of cis-diamminedichloroplatinum(II) resistance: a review. | Br J Cancer | 1992 | https://conductscience.org/library/papers/1503895 | PubMed |
| 1475197 | Repair synthesis by human cell extracts in cisplatin-damaged DNA is preferentially determined by minor adducts. | Nucleic Acids Res | 1992 | https://conductscience.org/library/papers/1475197 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3045443
GET https://conductscience.org/api/papers/v1/3045443/references?page=2